BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 26192917)

  • 1. Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma.
    Jiang L; Gu ZH; Yan ZX; Zhao X; Xie YY; Zhang ZG; Pan CM; Hu Y; Cai CP; Dong Y; Huang JY; Wang L; Shen Y; Meng G; Zhou JF; Hu JD; Wang JF; Liu YH; Yang LH; Zhang F; Wang JM; Wang Z; Peng ZG; Chen FY; Sun ZM; Ding H; Shi JM; Hou J; Yan JS; Shi JY; Xu L; Li Y; Lu J; Zheng Z; Xue W; Zhao WL; Chen Z; Chen SJ
    Nat Genet; 2015 Sep; 47(9):1061-6. PubMed ID: 26192917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent Mutations in Natural Killer/T Cell Lymphoma.
    Zhang Y; Li C; Xue W; Zhang M; Li Z
    Cell Physiol Biochem; 2018; 49(1):1-16. PubMed ID: 30134235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma.
    Koo GC; Tan SY; Tang T; Poon SL; Allen GE; Tan L; Chong SC; Ong WS; Tay K; Tao M; Quek R; Loong S; Yeoh KW; Yap SP; Lee KA; Lim LC; Tan D; Goh C; Cutcutache I; Yu W; Ng CC; Rajasegaran V; Heng HL; Gan A; Ong CK; Rozen S; Tan P; Teh BT; Lim ST
    Cancer Discov; 2012 Jul; 2(7):591-7. PubMed ID: 22705984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
    Dufva O; Kankainen M; Kelkka T; Sekiguchi N; Awad SA; Eldfors S; Yadav B; Kuusanmäki H; Malani D; Andersson EI; Pietarinen P; Saikko L; Kovanen PE; Ojala T; Lee DA; Loughran TP; Nakazawa H; Suzumiya J; Suzuki R; Ko YH; Kim WS; Chuang SS; Aittokallio T; Chan WC; Ohshima K; Ishida F; Mustjoki S
    Nat Commun; 2018 Apr; 9(1):1567. PubMed ID: 29674644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in multiple omics of natural-killer/T cell lymphoma.
    Xiong J; Zhao WL
    J Hematol Oncol; 2018 Dec; 11(1):134. PubMed ID: 30514323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Full-spectral genome analysis of natural killer/T cell lymphoma highlights impacts of genome instability in driving its progression.
    Chen Z; Huang H; Hong H; Huang H; Weng H; Yu L; Xiao J; Wang Z; Fang X; Yao Y; Yue JX; Lin T
    Genome Med; 2024 Apr; 16(1):48. PubMed ID: 38566223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma.
    Li Z; Zhang X; Xue W; Zhang Y; Li C; Song Y; Mei M; Lu L; Wang Y; Zhou Z; Jin M; Bian Y; Zhang L; Wang X; Li L; Li X; Fu X; Sun Z; Wu J; Nan F; Chang Y; Yan J; Yu H; Feng X; Wang G; Zhang D; Fu X; Zhang Y; Young KH; Li W; Zhang M
    Nat Commun; 2019 Sep; 10(1):4209. PubMed ID: 31527657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
    Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What we should know about natural killer/T-cell lymphomas.
    Xiong J; Zhao W
    Hematol Oncol; 2019 Jun; 37 Suppl 1():75-81. PubMed ID: 31187536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WP1066 exhibits antitumor efficacy in nasal‑type natural killer/T-cell lymphoma cells through downregulation of the STAT3 signaling pathway.
    Geng L; Li X; Zhou X; Fang X; Yuan D; Wang X
    Oncol Rep; 2016 Nov; 36(5):2868-2874. PubMed ID: 27633398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and prognosis of rrDLBCL with TP53 mutations and a high-risk subgroup represented by the co-mutations of DDX3X-TP53.
    Gao F; Hu K; Zheng P; Shi H; Ke X
    Cancer Med; 2023 May; 12(9):10267-10279. PubMed ID: 36971051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational Analysis of Extranodal NK/T-Cell Lymphoma Using Targeted Sequencing with a Comprehensive Cancer Panel.
    Choi S; Go JH; Kim EK; Lee H; Lee WM; Cho CS; Han K
    Genomics Inform; 2016 Sep; 14(3):78-84. PubMed ID: 27729836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma.
    Xiong J; Cui BW; Wang N; Dai YT; Zhang H; Wang CF; Zhong HJ; Cheng S; Ou-Yang BS; Hu Y; Zhang X; Xu B; Qian WB; Tao R; Yan F; Hu JD; Hou M; Ma XJ; Wang X; Liu YH; Zhu ZM; Huang XB; Liu L; Wu CY; Huang L; Shen YF; Huang RB; Xu JY; Wang C; Wu DP; Yu L; Li JF; Xu PP; Wang L; Huang JY; Chen SJ; Zhao WL
    Cancer Cell; 2020 Mar; 37(3):403-419.e6. PubMed ID: 32183952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and molecular genomic features of monomorphic epitheliotropic intestinal T-cell lymphoma in the Chinese population: a study of 20 cases.
    Chen C; Gong Y; Yang Y; Xia Q; Rao Q; Shao Y; Zhu L; Zhang J; Li X; Ji P; Zhai B; Zhang X; Zhang Z
    Diagn Pathol; 2021 Dec; 16(1):114. PubMed ID: 34895266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
    Vose J; Armitage J; Weisenburger D;
    J Clin Oncol; 2008 Sep; 26(25):4124-30. PubMed ID: 18626005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
    Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
    Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in ATR in nasal NK/T-cell lymphoma and chronic active Epstein-Barr virus infection.
    Liu A; Takakuwa T; Luo WJ; Fujita S; Aozasa K
    Cancer Sci; 2006 Jul; 97(7):605-10. PubMed ID: 16827800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cell adhesion molecules and chemokine receptors: angioinvasiveness in nasal NK/T-cell lymphoma.
    Liu A; Nakatsuka S; Yang WI; Kojya S; Aozasa K
    Oncol Rep; 2005 Apr; 13(4):613-20. PubMed ID: 15756432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.
    Lee S; Park HY; Kang SY; Kim SJ; Hwang J; Lee S; Kwak SH; Park KS; Yoo HY; Kim WS; Kim JI; Ko YH
    Oncotarget; 2015 Jul; 6(19):17764-76. PubMed ID: 25980440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated janus kinase 3 expression not by activating mutations identified in natural killer/T-cell lymphoma.
    Guo Y; Arakawa F; Miyoshi H; Niino D; Kawano R; Ohshima K
    Pathol Int; 2014 Jun; 64(6):263-6. PubMed ID: 24965108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.